3,042 reports of this reaction
16.0% of all TIMOLOL reports
#1 most reported adverse reaction
TREATMENT FAILURE is the #1 most commonly reported adverse reaction for TIMOLOL, manufactured by Thea Pharma Inc.. There are 3,042 FDA adverse event reports linking TIMOLOL to TREATMENT FAILURE. This represents approximately 16.0% of all 19,009 adverse event reports for this drug.
Patients taking TIMOLOL who experience treatment failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
TREATMENT FAILURE is a frequently reported adverse event for TIMOLOL, accounting for a significant proportion of all reports.
In addition to treatment failure, the following adverse reactions have been reported for TIMOLOL:
The following drugs have also been linked to treatment failure in FDA adverse event reports:
TREATMENT FAILURE has been reported as an adverse event in 3,042 FDA reports for TIMOLOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
TREATMENT FAILURE accounts for approximately 16.0% of all adverse event reports for TIMOLOL, making it one of the most commonly reported side effect.
If you experience treatment failure while taking TIMOLOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.